Algorithmic Biologics builds ultra-multiplexed universal detection systems for companion diagnostics, screening and surveillance.
Published
Signal category
Products & Services
Quote
“AlgoBio builds ultra-multiplexed universal detection systems for companion diagnostics, screening and surveillance.”
— Algorithmic Biologics team
Company
Algorithmic Biologics
Bringing scale efficiencies to molecular discovery and diagnostics.
- Industry
- Biotechnology Research
- Location
- Foster City, US
- Company size
- 18 employees
We are a deep-tech company combining mathematics, computer science, and biology to transform molecular assay design at scale. Our Sequence Transduction technology enables highly multiplexed, cost-effective diagnostics, detecting hundreds of targets in minimal reactions with MRD- level sensitivity (<0.02%) and rapid assay development (1–3 months, ~98% success). Our proprietary Tapestry platform enables software-driven combinatorial multiplexing atop standard molecular tests like NGS and PCR, delivering significant cost savings (of up to 60%) with improved accuracy. Tapestry partners with diagnostic and research labs globally to execute large volume molecular testing. We are a true partner to biopharma, diagnostic manufacturers and molecular testing labs worldwide. We have offices in San Francisco and Bangalore.